Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -22.946% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) O=C(NCCN1CCCCC1)c1ccc2c(c1)OCCO2
b.) Cc1ccc(C)c(N2CCN(S(=O)(=O)c3cccc4cccnc34)CC2)c1
Answer: b. Cc1ccc(C)c(N2CCN(S(=O)(=O)c3cccc4cccnc34)CC2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(C)c(N2CCN(S(=O)(=O)c3cccc4cccnc34)CC2)c1
Cc1ccc(C)c(N2CCN(S(=O)(=O)c3cccc4cccnc34)CC2)c1
8-[4-(2,5-dimethylphenyl)piperazin-1-yl]sulfonylquinoline